Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 8:338:a3083.
doi: 10.1136/bmj.a3083.

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study

Wouter de Ruijter  1 , Rudi G J Westendorp, Willem J J Assendelft, Wendy P J den Elzen, Anton J M de Craen, Saskia le Cessie, Jacobijn Gussekloo
Affiliations

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study

Wouter de Ruijter et al. BMJ. .

Abstract

Objectives: To investigate the performance of classic risk factors, and of some new biomarkers, in predicting cardiovascular mortality in very old people from the general population with no history of cardiovascular disease.

Design: The Leiden 85-plus Study (1997-2004) is an observational prospective cohort study with 5 years of follow-up.

Setting: General population of the city of Leiden, the Netherlands.

Participants: Population based sample of participants aged 85 years (215 women and 87 men) with no history of cardiovascular disease; no other exclusion criteria. Main measurements Cause specific mortality was registered during follow-up. All classic risk factors included in the Framingham risk score (sex, systolic blood pressure, total and high density lipoprotein cholesterol, diabetes mellitus, smoking and electrocardiogram based left ventricular hypertrophy), as well as plasma concentrations of the new biomarkers homocysteine, folic acid, C reactive protein, and interleukin 6, were assessed at baseline.

Results: During follow-up, 108 of the 302 participants died; 32% (35/108) of deaths were from cardiovascular causes. Classic risk factors did not predict cardiovascular mortality when used in the Framingham risk score (area under receiver operating characteristic curve 0.53, 95% confidence interval 0.42 to 0.63) or in a newly calibrated model (0.53, 0.43 to 0.64). Of the new biomarkers studied, homocysteine had most predictive power (0.65, 0.55 to 0.75). Entering any additional risk factor or combination of factors into the homocysteine prediction model did not increase its discriminative power.

Conclusions: In very old people from the general population with no history of cardiovascular disease, concentrations of homocysteine alone can accurately identify those at high risk of cardiovascular mortality, whereas classic risk factors included in the Framingham risk score do not. These preliminary findings warrant validation in a separate cohort.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None
Fig 1 Cumulative cardiovascular mortality depending on tertiles of risk obtained from classic risk factors, weighted on the basis of Framingham risk score, or newly calibrated risk score from the Leiden 85-plus Study
None
Fig 2 Cumulative cardiovascular mortality depending on tertiles of risk obtained from prediction models using homocysteine, folic acid, C reactive protein and interleukin 6
None
Fig 3 Receiver operating characteristic curves showing performance of three prediction models for 5 year cardiovascular mortality based on Framingham risk score, homocysteine concentrations only, and homocysteine concentrations plus Framingham risk score
See this image and copyright information in PMC

References

    1. McDermott MM. The international pandemic of chronic cardiovascular disease. JAMA 2007;297:1253-5. - PubMed
    1. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European cardiovascular disease statistics. London: British Heart Foundation, 2005.
    1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics—2007 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2007;115:e69-171. - PubMed
    1. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 1994;272:1932-8. - PubMed
    1. Kannel WB. Cardiovascular disease preventive measures for the older patient: An epidemiologic perspective. Am J Geriatr Cardiol 2006;15:382-8. - PubMed

Publication types